152 related articles for article (PubMed ID: 31899856)
1. Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative data.
Weingart SN; Nelson J; Koethe B; Yaghi O; Dunning S; Feldman A; Kent DM; Lipitz-Snyderman A
Cancer Med; 2020 Feb; 9(4):1462-1472. PubMed ID: 31899856
[TBL] [Abstract][Full Text] [Related]
2. Association between cancer-specific adverse event triggers and mortality: A validation study.
Weingart SN; Nelson J; Koethe B; Yaghi O; Dunning S; Feldman A; Kent D; Lipitz-Snyderman A
Cancer Med; 2020 Jun; 9(12):4447-4459. PubMed ID: 32285614
[TBL] [Abstract][Full Text] [Related]
3. Performance of a Trigger Tool for Identifying Adverse Events in Oncology.
Lipitz-Snyderman A; Classen D; Pfister D; Killen A; Atoria CL; Fortier E; Epstein AS; Anderson C; Weingart SN
J Oncol Pract; 2017 Mar; 13(3):e223-e230. PubMed ID: 28095173
[TBL] [Abstract][Full Text] [Related]
4. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
[TBL] [Abstract][Full Text] [Related]
5. Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.
Lipitz-Snyderman A; Pfister D; Classen D; Atoria CL; Killen A; Epstein AS; Anderson C; Fortier E; Weingart SN
Cancer; 2017 Dec; 123(23):4728-4736. PubMed ID: 28817180
[TBL] [Abstract][Full Text] [Related]
6. Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care patients.
Brenner S; Detz A; López A; Horton C; Sarkar U
BMJ Qual Saf; 2012 Aug; 21(8):670-5. PubMed ID: 22626736
[TBL] [Abstract][Full Text] [Related]
7. Trigger Tool-Based Automated Adverse Event Detection in Electronic Health Records: Systematic Review.
Musy SN; Ausserhofer D; Schwendimann R; Rothen HU; Jeitziner MM; Rutjes AW; Simon M
J Med Internet Res; 2018 May; 20(5):e198. PubMed ID: 29848467
[TBL] [Abstract][Full Text] [Related]
8. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
[TBL] [Abstract][Full Text] [Related]
9. Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method.
Hu Q; Qin Z; Zhan M; Wu B; Chen Z; Xu T
Int J Clin Pharm; 2019 Oct; 41(5):1174-1183. PubMed ID: 31254152
[TBL] [Abstract][Full Text] [Related]
10. Mitigating risk in Norwegian psychiatric care: Identifying triggers of adverse events through Global Trigger Tool for psychiatric care.
Okkenhaug A; Tritter JQ; Myklebust TÅ; Deilkås ET; Meirik K; Landstad BJ
Int J Risk Saf Med; 2019; 30(4):203-216. PubMed ID: 31561389
[TBL] [Abstract][Full Text] [Related]
11. Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the Global Trigger Tool method.
Härkänen M; Kervinen M; Ahonen J; Voutilainen A; Turunen H; Vehviläinen-Julkunen K
J Clin Nurs; 2015 Feb; 24(3-4):582-91. PubMed ID: 25393838
[TBL] [Abstract][Full Text] [Related]
12. Validating methods used to identify non-adherence adverse drug events in Canadian administrative health data.
Wickham ME; McGrail KM; Law MR; Cragg A; Hohl CM
Br J Clin Pharmacol; 2024 May; 90(5):1240-1246. PubMed ID: 38320955
[TBL] [Abstract][Full Text] [Related]
13. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
[TBL] [Abstract][Full Text] [Related]
14. Validating the Chinese geriatric trigger tool and analyzing adverse drug event associated risk factors in elderly Chinese patients: A retrospective review.
Hu Q; Qin Z; Zhan M; Chen Z; Wu B; Xu T
PLoS One; 2020; 15(4):e0232095. PubMed ID: 32343726
[TBL] [Abstract][Full Text] [Related]
15. Proposal of a trigger tool to assess adverse events in dental care.
Corrêa CDTSO; Mendes W
Cad Saude Publica; 2017 Nov; 33(11):e00053217. PubMed ID: 29166475
[TBL] [Abstract][Full Text] [Related]
16. Electronic health record-based triggers to detect potential delays in cancer diagnosis.
Murphy DR; Laxmisan A; Reis BA; Thomas EJ; Esquivel A; Forjuoh SN; Parikh R; Khan MM; Singh H
BMJ Qual Saf; 2014 Jan; 23(1):8-16. PubMed ID: 23873756
[TBL] [Abstract][Full Text] [Related]
17. Characteristics associated with the occurrence of adverse events: a retrospective medical record review using the Global Trigger Tool in a fully digitalized tertiary teaching hospital in Korea.
Hwang JI; Chin HJ; Chang YS
J Eval Clin Pract; 2014 Feb; 20(1):27-35. PubMed ID: 23890097
[TBL] [Abstract][Full Text] [Related]
18. Adverse events in women switching from olaparib capsules to tablets: retrospective observational study of US claims data.
Banerjee S; Davidson R; McLaurin K; Sawyer W; Long GH
Future Oncol; 2020 Apr; 16(11):643-654. PubMed ID: 32228096
[No Abstract] [Full Text] [Related]
19. Development of an electronic trigger tool at a children's hospital within an academic medical center.
Fortenberry M; Odinet J; Shah P; McKinzie C; Murphy K; Faircloth CB; Falato C; Pappas A
Am J Health Syst Pharm; 2019 Nov; 76(Supplement_4):S107-S113. PubMed ID: 31724037
[TBL] [Abstract][Full Text] [Related]
20. Pharmacovigilance in oncology.
Baldo P; Fornasier G; Ciolfi L; Sartor I; Francescon S
Int J Clin Pharm; 2018 Aug; 40(4):832-841. PubMed ID: 30069667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
